Follow
Hanneke van Laarhoven
Hanneke van Laarhoven
Unknown affiliation
Verified email at amc.uva.nl
Title
Cited by
Cited by
Year
Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial
J Shapiro, JJB Van Lanschot, MCCM Hulshof, P van Hagen, ...
The lancet oncology 16 (9), 1090-1098, 2015
23072015
Laparoscopic versus open pancreatoduodenectomy for pancreatic or periampullary tumours (LEOPARD-2): a multicentre, patient-blinded, randomised controlled phase 2/3 trial
J Van Hilst, T de Rooij, K Bosscha, DJ Brinkman, S van Dieren, ...
The lancet Gastroenterology & hepatology 4 (3), 199-207, 2019
5102019
Chemotherapy versus chemoradiotherapy after surgery and preoperative chemotherapy for resectable gastric cancer (CRITICS): an international, open-label, randomised phase 3 trial
A Cats, EPM Jansen, NCT van Grieken, K Sikorska, P Lind, M Nordsmark, ...
The lancet oncology 19 (5), 616-628, 2018
4702018
Artificial reporter gene providing MRI contrast based on proton exchange
AA Gilad, MT McMahon, P Walczak, PT Winnard Jr, V Raman, ...
Nature biotechnology 25 (2), 217-219, 2007
4542007
Triple-negative breast cancer: present challenges and new perspectives
F Podo, LMC Buydens, H Degani, R Hilhorst, E Klipp, IS Gribbestad, ...
Molecular oncology 4 (3), 209-229, 2010
3992010
Ten-year outcome of neoadjuvant chemoradiotherapy plus surgery for esophageal cancer: the randomized controlled CROSS trial
BM Eyck, JJB van Lanschot, MCCM Hulshof, BJ van der Wilk, J Shapiro, ...
Journal of Clinical Oncology 39 (18), 1995-2004, 2021
3612021
Venous thromboembolism in cancer patients: a population-based cohort study
FI Mulder, E Horvàth-Puhó, N van Es, HWM Van Laarhoven, L Pedersen, ...
Blood, The Journal of the American Society of Hematology 137 (14), 1959-1969, 2021
3402021
Treatment related impairments in arm and shoulder in patients with breast cancer: a systematic review
JT Hidding, CHG Beurskens, PJ van der Wees, HWM van Laarhoven, ...
PloS one 9 (5), e96748, 2014
3212014
The assessment of fatigue: Psychometric qualities and norms for the Checklist individual strength
M Worm-Smeitink, M Gielissen, L Bloot, HWM Van Laarhoven, ...
Journal of psychosomatic research 98, 40-46, 2017
2822017
Monitoring and predicting response to therapy with 18F-FDG PET in colorectal cancer: a systematic review
LF de Geus-Oei, D Vriens, HWM van Laarhoven, WTA van der Graaf, ...
Journal of Nuclear Medicine 50 (Suppl 1), 43S-54S, 2009
2442009
Detection of residual disease after neoadjuvant chemoradiotherapy for oesophageal cancer (preSANO): a prospective multicentre, diagnostic cohort study
BJ Noordman, MCW Spaander, R Valkema, BPL Wijnhoven, ...
The Lancet Oncology 19 (7), 965-974, 2018
2362018
The Cancer Worry Scale: detecting fear of recurrence in breast cancer survivors
JAE Custers, SW van den Berg, HWM van Laarhoven, EMA Bleiker, ...
Cancer Nursing 37 (1), E44-E50, 2014
2362014
Beyond RECIST: molecular and functional imaging techniques for evaluation of response to targeted therapy
IME Desar, CML Van Herpen, HWM Van Laarhoven, JO Barentsz, ...
Cancer treatment reviews 35 (4), 309-321, 2009
1992009
White blood cell and cell-free DNA analyses for detection of residual disease in gastric cancer
A Leal, NCT van Grieken, DN Palsgrove, J Phallen, JE Medina, C Hruban, ...
Nature communications 11 (1), 525, 2020
1912020
Measurement properties of instruments for measuring of lymphedema: systematic review
JT Hidding, PB Viehoff, CHG Beurskens, HWM van Laarhoven, ...
Physical therapy 96 (12), 1965-1981, 2016
1842016
Randomized study on dose escalation in definitive chemoradiation for patients with locally advanced esophageal cancer (ARTDECO study)
MCCM Hulshof, ED Geijsen, T Rozema, V Oppedijk, J Buijsen, KJ Neelis, ...
Journal of Clinical Oncology 39 (25), 2816-2824, 2021
1692021
Stromal-derived interleukin 6 drives epithelial-to-mesenchymal transition and therapy resistance in esophageal adenocarcinoma
EA Ebbing, AP van der Zalm, A Steins, A Creemers, S Hermsen, ...
Proceedings of the National Academy of Sciences 116 (6), 2237-2242, 2019
1612019
Inflammatory breast cancer: an overview
DJP Van Uden, HWM Van Laarhoven, AH Westenberg, JHW de Wilt, ...
Critical reviews in oncology/hematology 93 (2), 116-126, 2015
1512015
Neoadjuvant chemoradiotherapy combined with atezolizumab for resectable esophageal adenocarcinoma: a single-arm phase II feasibility trial (PERFECT)
T Van Den Ende, NC De Clercq, MI van Berge Henegouwen, SS Gisbertz, ...
Clinical Cancer Research 27 (12), 3351-3359, 2021
1502021
Impact of the coronavirus disease 2019 pandemic on cancer treatment: the patients’ perspective
K De Joode, DW Dumoulin, V Engelen, HJ Bloemendal, M Verheij, ...
European journal of cancer 136, 132-139, 2020
1472020
The system can't perform the operation now. Try again later.
Articles 1–20